215 related articles for article (PubMed ID: 33254027)
21. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Yoo YD; Lee DH; Cha-Molstad H; Kim H; Mun SR; Ji C; Park SH; Sung KS; Choi SA; Hwang J; Park DM; Kim SK; Park KJ; Kang SH; Oh SC; Ciechanover A; Lee YJ; Kim BY; Kwon YT
EMBO Rep; 2017 Jan; 18(1):150-168. PubMed ID: 27993939
[TBL] [Abstract][Full Text] [Related]
22. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.
Yuan S; Lu Y; Yang J; Chen G; Kim S; Feng L; Ogasawara M; Hammoudi N; Lu W; Zhang H; Liu J; Colman H; Lee JS; Li XN; Xu RH; Huang P; Wang F
Stem Cell Res Ther; 2015 Oct; 6():198. PubMed ID: 26472041
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
24. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.
Zubiete-Franco I; García-Rodríguez JL; Lopitz-Otsoa F; Serrano-Macia M; Simon J; Fernández-Tussy P; Barbier-Torres L; Fernández-Ramos D; Gutiérrez-de-Juan V; López de Davalillo S; Carlevaris O; Beguiristain Gómez A; Villa E; Calvisi D; Martín C; Berra E; Aspichueta P; Beraza N; Varela-Rey M; Ávila M; Rodríguez MS; Mato JM; Díaz-Moreno I; Díaz-Quintana A; Delgado TC; Martínez-Chantar ML
EBioMedicine; 2019 Feb; 40():406-421. PubMed ID: 30594553
[TBL] [Abstract][Full Text] [Related]
25. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
[TBL] [Abstract][Full Text] [Related]
26. Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.
Tsen AR; Long PM; Driscoll HE; Davies MT; Teasdale BA; Penar PL; Pendlebury WW; Spees JL; Lawler SE; Viapiano MS; Jaworski DM
Int J Cancer; 2014 Mar; 134(6):1300-10. PubMed ID: 23996800
[TBL] [Abstract][Full Text] [Related]
27. Effective elimination of cancer stem cells by a novel drug combination strategy.
Yuan S; Wang F; Chen G; Zhang H; Feng L; Wang L; Colman H; Keating MJ; Li X; Xu RH; Wang J; Huang P
Stem Cells; 2013 Jan; 31(1):23-34. PubMed ID: 23132831
[TBL] [Abstract][Full Text] [Related]
28. Rewiring of purine metabolism in response to acidosis stress in glioma stem cells.
Xu X; Wang L; Zang Q; Li S; Li L; Wang Z; He J; Qiang B; Han W; Zhang R; Peng X; Abliz Z
Cell Death Dis; 2021 Mar; 12(3):277. PubMed ID: 33723244
[TBL] [Abstract][Full Text] [Related]
29. The role of Src family kinases in growth and migration of glioma stem cells.
Han X; Zhang W; Yang X; Wheeler CG; Langford CP; Wu L; Filippova N; Friedman GK; Ding Q; Fathallah-Shaykh HM; Gillespie GY; Nabors LB
Int J Oncol; 2014 Jul; 45(1):302-10. PubMed ID: 24819299
[TBL] [Abstract][Full Text] [Related]
30. LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4.
Han S; Wang C; Qin X; Xia J; Wu A
J Exp Clin Cancer Res; 2017 Jun; 36(1):83. PubMed ID: 28641579
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
[TBL] [Abstract][Full Text] [Related]
33. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
34. R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells.
Sun S; Xue D; Chen Z; Ou-Yang Y; Zhang J; Mai J; Gu J; Lu W; Liu X; Liu W; Sheng L; Lu B; Lin Y; Xing F; Chen Z; Mou Y; Yan G; Zhu W; Sai K
Cell Death Dis; 2019 May; 10(5):358. PubMed ID: 31043589
[TBL] [Abstract][Full Text] [Related]
35. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
36. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
37. Erratum to "Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43
Pelaz SG; Jaraíz-Rodríguez M; Álvarez-Vázquez A; Talaverón R; García-Vicente L; Flores-Hernández R; de Cedrón MG; Tabernero M; de Molina AR; Lillo C; Medina JM; Tabernero A
EBioMedicine; 2021 Dec; 74():103752. PubMed ID: 34911027
[No Abstract] [Full Text] [Related]
38. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.
Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
[No Abstract] [Full Text] [Related]
39. Targeting A20 decreases glioma stem cell survival and tumor growth.
Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
[TBL] [Abstract][Full Text] [Related]
40. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]